17-beta-hydroxysteroid dehydrogenase deficiency: Difference between revisions
No edit summary |
Jose Loyola (talk | contribs) |
||
(2 intermediate revisions by 2 users not shown) | |||
Line 18: | Line 18: | ||
{{SK}} 17-beta hydroxysteroid dehydrogenase III deficiency, 17-ketosteroid reductase deficiency of testis, 17-KSR deficiency, Neutral 17-beta-hydroxysteroid oxidoreductase deficiency, Male Pseudohermaphroditism with gynecomastia, Testosterone 17-beta-dehydrogenase deficiency | {{SK}} 17-beta hydroxysteroid dehydrogenase III deficiency, 17-ketosteroid reductase deficiency of testis, 17-KSR deficiency, Neutral 17-beta-hydroxysteroid oxidoreductase deficiency, Male Pseudohermaphroditism with gynecomastia, Testosterone 17-beta-dehydrogenase deficiency | ||
==[[17-beta-hydroxysteroid dehydrogenase | ==[[17-beta-hydroxysteroid dehydrogenase deficiency overview|Overview]]== | ||
==[[17-beta-hydroxysteroid dehydrogenase deficiency historical perspective|Historical Perspective]]== | ==[[17-beta-hydroxysteroid dehydrogenase deficiency historical perspective|Historical Perspective]]== |
Latest revision as of 18:13, 9 May 2022
congenital adrenal hyperplasia due to CYP17A1 deficiencies | |
OMIM | 264300 |
---|---|
DiseasesDB | 32638 |
17-beta-hydroxysteroid dehydrogenase deficiency Microchapters |
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases |
---|
Diagnosis |
Treatment |
Case Studies |
17-beta-hydroxysteroid dehydrogenase deficiency On the Web |
American Roentgen Ray Society Images of 17-beta-hydroxysteroid dehydrogenase deficiency |
Directions to Hospitals Treating 17-beta-hydroxysteroid dehydrogenase deficiency |
Risk calculators and risk factors for 17-beta-hydroxysteroid dehydrogenase deficiency |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Abdulkerim Yassin, M.B.B.S[2]
Synonyms and keywords: 17-beta hydroxysteroid dehydrogenase III deficiency, 17-ketosteroid reductase deficiency of testis, 17-KSR deficiency, Neutral 17-beta-hydroxysteroid oxidoreductase deficiency, Male Pseudohermaphroditism with gynecomastia, Testosterone 17-beta-dehydrogenase deficiency
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating 17-beta-hydroxysteroid dehydrogenase deficiency from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Laboratory Findings | Molecular Genetic Studies | Genotyping | Pelvic X Ray | CT | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical Therapy | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies